Monoclonal antibody | |
---|---|
Type | ? |
Source | Mouse |
Target | MUC1 |
Clinical data | |
Trade names | Theragyn |
Routes of administration | Intraperitoneal |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
![]() ![]() |
Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour.[1] As of 2009[update], it is undergoing Phase III clinical trials.[2]
It has been granted orphan drug status in Europe.[3]
![]() | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
![]() | This antineoplasticorimmunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |